Ocular and Neurological FIP: A 2026 Guide for Cat Owners
- DVM Vien
- Jun 1
- 4 min read
Quick answer (for FIP cat owners and search engines)
Ocular FIP (eye involvement — uveitis, vision changes, retinal lesions) and neurological FIP (CNS involvement — ataxia, seizures, behavior changes, head tilt) are the two FIP forms most often missed or misdiagnosed, and both require higher GS-441524 doses than wet/dry FIP to achieve remission. The standard dose of 6 mg/kg/day is not enough for these forms. Ocular FIP typically needs 8 mg/kg/day; neurological FIP needs 10 mg/kg/day or higher. Cats treated at the correct higher dose still achieve remission rates above 80% in published case series, but treating these forms at the wet/dry dose is one of the most common preventable causes of treatment failure.
Why ocular and neurological FIP are different
Both forms reflect the feline coronavirus crossing into immune-privileged tissues — the eye and the central nervous system. These tissues have a blood-eye barrier and blood-brain barrier that limit drug penetration, limited immune surveillance allowing the virus to persist, and anatomy where small amounts of inflammation cause visible neurological or visual signs.
Because of the barriers, a wet/dry FIP dose simply does not produce enough drug concentration inside the eye or CNS. The treatment is the same molecule (GS-441524) — but the dose must be higher.
Recognising ocular FIP
Ocular FIP can occur on its own or as part of a wider FIP picture. Watch for:
Anterior uveitis — cloudy eye, change in iris colour, light sensitivity, squinting
Aqueous flare — visible haze inside the front chamber of the eye
Retinal lesions — only visible to a vet on fundoscopy; can include retinal detachment, hemorrhage
Hyphema — blood in the front chamber of the eye
Sudden vision change or blindness — emergency presentation
Important: many of these signs are also seen in toxoplasmosis, FIV, FeLV, and other systemic diseases. A vet ophthalmology exam plus systemic workup (CBC, biochemistry, A:G ratio, AGP, plus toxoplasma serology where indicated) is needed before assuming FIP.
Recognising neurological FIP
Neurological FIP signs can develop quickly or insidiously. Watch for:
Ataxia — unsteady gait, swaying, falling
Head tilt or nystagmus (involuntary eye movement)
Seizures — can be focal (facial twitching, one limb) or generalised
Behaviour change — hiding, aggression, vocalisation, disorientation
Hyperaesthesia — unusual sensitivity to touch, especially over the back
Cranial nerve deficits — facial paralysis, swallowing difficulty, vision change
Tremors — especially of the head or limbs
Approximately 70% of FIP cases involve some CNS component on advanced imaging, but clinically obvious neurological signs are present in roughly 10–20% of cases. Some cats have very subtle changes (slight behavior change, occasional twitching) that owners notice but vets may miss without specific questioning.
Diagnostic workup
Full neurological examination by a vet (cranial nerves, postural reactions, spinal reflexes, mentation)
Ophthalmology exam including slit lamp and fundoscopy
Bloodwork: CBC, biochemistry, total protein, A:G ratio, AGP (alpha-1 acid glycoprotein)
CSF tap — high protein, elevated cells, sometimes PCR-positive for FCoV
MRI — gold-standard for visualising granulomatous lesions, meningeal enhancement, hydrocephalus
In smaller cities or rural areas, MRI may require referral to a university hospital or specialist centre. FipDr's consultation team can help identify the nearest specialist for your region.
Dosing: the most important detail
Ocular FIP: 8–10 mg/kg/day subcutaneous GS-441524 (some clinicians start at 8, titrate to 10 if ocular signs do not improve by week 4)
Neurological FIP: 10–15 mg/kg/day; some severe cases dose 12–15 mg/kg/day from day 1
Combined ocular + neurological: treat to the higher dose (neurological)
Higher doses are well-tolerated by most cats; injection volume increases proportionally, which sometimes pushes owners toward split-dose (morning + evening) to reduce injection-site discomfort. Do not treat ocular or neurological FIP at the 6 mg/kg/day wet/dry dose. Under-dosing in these forms is the single most preventable cause of treatment failure or relapse.
What recovery looks like
Anterior uveitis can improve within 7–14 days once the correct dose is reached
Ataxia and behavior changes often improve over 2–4 weeks
Seizures generally reduce in frequency by week 2–3; some cats need concurrent anticonvulsants (levetiracetam is common)
Retinal lesions can leave permanent scarring even after the disease clears — but functional vision often returns
A cat that was unable to walk at diagnosis but is walking at month 3 is a typical neurological FIP success story.
The 84-day observation window
After day 84, the observation window is even more critical for these forms because relapse risk is slightly higher. Monthly bloodwork plus monthly vet examination (with ophthalmology where indicated) is the standard. See our FIP Relapse guide for the full observation framework.
Why specialist consultation matters more here
Ocular and neurological FIP cases are the ones where FipDr's veterinary team adds the most value. Most general-practice vets see 1–2 FIP cases per year and may not have managed an ocular or neurological case at all. Our consulting vets have managed hundreds. The cost of getting the dose wrong in these forms is high — and entirely preventable.
Start with a free consultation
If your vet has mentioned eye changes, head tilt, ataxia, seizures, or any other neurological sign in your cat, before you start treatment, talk to us. We confirm whether the ocular or neurological FIP picture fits, calculate the correct (higher) dose for your cat's weight and form, and coordinate with your local vet on imaging or specialist referral.
Related reading
Medical disclaimer: This article is educational. Ocular and neurological FIP diagnosis and dosing must be confirmed by a treating veterinarian. Sources: Pedersen et al., 2019 (UC Davis); subsequent case series in Journal of Feline Medicine and Surgery; ABCD European Advisory Board on Cat Diseases 2025 guidelines.